Iferanserin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Iferanserin
Iferanserin.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
Formula C23H28N2O
Molar mass 348.481 g/mol
3D model (JSmol)

Iferanserin (INN; VEN-309) is a drug which acts as a selective 5-HT2A receptor antagonist.[1] It is under development as an intra-rectal formulation for the treatment of hemorrhoid disease, and as of February 2012, is in phase IIb clinical trials.[1]

References[edit]